FDA Investigator Joy P Matthias
Joy P Matthias has conducted inspections on 205 sites in 10 countries as of 30 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
205
Last Inspection Date:
30 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India,
United States of America,
El Salvador,
France,
Russian Federation,
Mexico,
Poland,
Bulgaria,
Chile,
Honduras
FDA Investigators that have inspected at least one site in common with Joy P Matthias:
Affiong Flores,
Alanna L Mussawwir Bias,
Albert Thompson,
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Amanda E Lewin, PhD,
Amanda T Zick,
Amber D Brodas,
Amy Kim,
Amy Wyan Mai,
Andrace L Deyampert,
Andrew B Paglia, DPM,
Andrew Byro,
Andrew F Cohen,
Andrew J Garufi,
Angela Jourdain,
Ann B Okon,
Ann M Stewart,
Anna M Alexander,
Anthony E Keller, RPh,
Anthony Kovalenko,
Anthony N Onianwa,
Anthony R Rauert,
Arduino Frankovic,
Armia A Beshay,
Arthur G Hurst,
Ashley Defilippis,
Ashley Polizzotto,
Ayorinde O Babalola,
Aziz A Mamur,
Barbara J Maulfair,
Benton M Ketron,
Bernardica T Sculac Stern,
Betsy C Galliher,
Betty M Ng Lee,
Bijoy Panicker,
Brandon J Kocurek,
Brian J Ryan,
Bruce G Cooper,
Camille D Monde,
Carolyn J Cook,
Carrie E Jolly,
Catherine M Beer,
Chagai L Winoker,
Charisse K Green,
Charles D Brown,
Christian Parra,
Christine M Rivera,
Christopher M Elliott,
Christopher S Fields,
Courtney N Long,
Dana A Razzano,
Daniel L Aisen,
Dave M Deroche,
David A Carlson,
David A Laplante,
David A Trent Carlson,
David J Leray,
David M Mcnew,
David R Delucia,
David R Heiar,
Deborah J Parris,
Debra D Devlieger,
Deep R Parikh,
Demitria J Xiradakis,
Denise L Terzian,
Desiree Hopkinson,
Devon O Seymour,
Dipesh K Shah,
Donald J Ullstrom,
Dongping Dai, PhD,
Douglas G Ng,
Dr. Robert C Horan, MD,
Edouard Viard,
Elizabeth H Davis,
Elizabeth H Slazak,
Emilio Z Azukwu,
Erica B Brush,
Erica B Raphael,
Erin L Nagel,
Eufemia G Gonzalez,
Evan Tong,
Evelyn Taha,
Feiyan Jin,
Frank Verni,
Gam S Zamil,
Gary J Lehr,
Gayle J Gehrman,
Geoffrey B Ward,
George C Amedro,
Gregson A Joseph,
Harry J Brewer,
Hilary K Wagner,
Iram R Hassan, PhD,
Irina Gaberman,
Isaac N Baah,
Jack J Lohne,
Jackson Y See,
Jacqueline S Warner,
James A Liubicich,
James D Bridges,
James H Robinson,
Janaysia N Trail,
Jane C Chen,
Jane M Kreis,
Janete F Guardia,
Jason Kwong,
Jay T Wong,
Jeanette L Mcginnis,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Jerri E Lothrop,
Joanne M Schlossin,
Joel R Merriman,
Jogy George,
John B Crowe,
Jonathan D Green,
Jose Ohernandez Guzman,
Jose V Obando,
Joseph A Famiglietti,
Joseph Duca,
Joseph J Vannelli,
Joseph Maselli,
Joseph Milcetic,
Joshua D Lopez,
Joy A Matthias,
Joyce A Williams,
Juan Rjimenez Garcia,
Judy Keihl,
Juliana Falla,
Jung K Kim,
Karen L Kosar,
Kathryn A Nagy,
Kellie Leveille,
Kerry D Noto,
Kerun Hardeo,
Kevin A Gonzalez,
Kevin K Cole,
Kim M Downing,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kristen C Jackson,
Kristen M Campbell,
Kwong P Lee,
Kyle J Spencer,
L Gnnmassimia Massimilla, PharmD,
Lata C Mathew, PhD,
Lauren E Blaser,
Lawrence W Farina,
Leena Thomas,
Leroy Terrelonge,
Linda M Sacco,
Linda R Kuchenthal,
Lisa Mathew,
Loretta J Miller,
LTJG Matthew R Palo,
Makini Cobourne Duval, PhD,
Manhar R Patel,
Marc S Neubauer,
Margaret N Klug,
Marie Elena C Puleo,
Marisa R Reeves,
Marlene L Davis,
Mary M Finn,
Matthew A Spataro,
Matthew C Watson,
Matthew D Schnittker,
Meghan L Fetterly,
Melinee C Minhas,
Melissa B Libby,
Melissa N Gregorio,
Melkamu Getie Kebtie, PhD,
Mercedes G Castillo,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael F Skelly, PhD,
Michael G Sinkevich,
Michael Levin,
Michael R Dominick,
Michael S Chuley,
Michael Serrano,
Michael W Burd,
Michele C Murray Schrade,
Michelle M Noe Varga,
Milan S Mcgorty,
Minh D Phan,
Morgan J Matthews,
Morris Paul,
Mouhamed H Halwani,
Nancy A Saxenian Emmons,
Neil J Bonzagni, PhD MPH,
Nicholas C Mendiola,
Nicole Vaught,
Olalere D Fasipe,
Omadevi Somai, Investigator,
Patrick A Bowen,
Patty P Kaewussdangkul,
Paul M Gelfand,
Paul Mouris,
Perez,
Perry T Nichols,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Philip F Istafanos, DMV, MS,
Ramni J Tandon,
Randi Lynn Spencer,
Randolph Campos Santiago,
Raymond M Lam,
Rebecca B Welch,
Richard J Anderson,
Rita F Monfort,
Robert C Steyert,
Robert E Moncayo,
Robert J Veitch,
Rochelle K Kimmel,
Ronald Ifraimov,
Russ E Davis,
Samina S Khan,
Samuel A Francis,
Sarah A Meehan,
Sarah A Wangseng,
Sasha M Latonis,
Satheesh Thomas,
Seemay A Lee,
Shamel Jaime,
Shannon A Dinardo,
Shantel S Brown,
Shantel S Tobias,
Shantelle I Hughes,
Shari L Kahn,
Sherrona J Robinson,
Shreya Shah,
Simone E Pitts,
Sonia E Ortiz,
Sony Mathews,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
Stanley Noneze,
Stephanie T Durso,
Stephen T Hansen,
Steven J Libal,
Sunita Vij,
Susan D Yuscius,
Susan T Hadman,
Syeda N Mahazabin,
Tamara M Simpson,
Tanya R Syffrard,
Tara K Carmody,
Tara K Normandin,
Tawny L Colling,
Terrance L Thomas,
Terry E Pierre,
Thomas J Mooney,
Thomas P Hansen,
Thomas W Gordon,
Tracy M Portelli,
Tyanna N Hadley,
Uduak M Inokon,
Valerie A Potopsingh,
Valerie Jgrecek Trinh,
Vanessa M Williams,
Vickie J Kanion,
Vincent T Duncan,
Wai H Lam,
Wayne J Meyer,
Wendy M Stone,
William M Rennells,
William P Chilton,
Winston R Alejo,
Xiaokuang Lai, PhD,
Xiaoping Guan,
Xikui Chen (nmi), PhD,
Yuyan Liang,
Yvonne M Santiago,
Zameer Farouk
Joy P Matthias's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2003 | FDA 483 Response | Epic Pharma, LLC - Form 483R, 2003-01-28 |
January, 2003 | EIR | Epic Pharma, LLC - EIR, 2003-01-16 |
March, 2018 | EIR | ScieGen Pharmaceuticals Inc. - EIR, 2018-03-14 |
December, 2020 | EIR | Regeneron Pharmaceuticals Inc - EIR, 2020-12-21 |
November, 2018 | EIR | Ascent Pharmaceuticals Inc - EIR, 2018-11-07 |
January, 2003 | FDA 483 | Epic Pharma, LLC - Form 483, 2003-01-16 |
February, 2009 | FDA 483 | Peregrina Cheese Corp. - Form 483, 2009-02-17 |
November, 2018 | FDA 483 | Epic Pharma, LLC - Form 483, 2018-11-06 |
July, 2005 | FDA 483 | D & M Smoked Fish, Inc. - Form 483, 2005-07-20 |
December, 2007 | FDA 483 | Peregrina Cheese Corp. - Form 483, 2007-12-21 |
April, 2015 | EIR | Bio-Botanica, Inc. - EIR, 2015-04-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more